CD4 counting technologies for HIV therapy monitoring in resource-poor settings--state-of-the-art and emerging microtechnologies.

Authors:
Macdara T Glynn
Macdara T Glynn
Biomedical Diagnostics Institute
David J Kinahan
David J Kinahan
Dublin City University
Ireland
Dr. Jens Ducree, Dr. rer. nat. habil. Dipl. Phys.
Dr. Jens Ducree, Dr. rer. nat. habil. Dipl. Phys.
Fraunhofer Project Centre at Dublin City University
Professor (Full)
microfluidics, Lab-on-a-Chip, hydrodynanmics, business development, project management, organisational leadership
Glasnevin, Dublin 9 | Ireland

Lab Chip 2013 Jul;13(14):2731-48

Biomedical Diagnostic Institute, National Centre for Sensor Research, School of Physical Sciences, Dublin City University, Dublin, Ireland.

Modern advancements in pharmaceuticals have provided individuals who have been infected with the human immunodeficiency virus (HIV) with the possibility of significantly extending their survival rates. When administered sufficiently soon after infection, antiretroviral therapy (ART) allows medical practitioners to control onset of the symptoms of the associated acquired immune deficiency syndrome (AIDS). Active monitoring of the immune system in both HIV patients and individuals who are regarded as "at-risk" is critical in the decision making process for when to start a patient on ART. A reliable and common method for such monitoring is to observe any decline in the number of CD4 expressing T-helper cells in the blood of a patient. However, the technology, expertise, infrastructure and costs to carry out such a diagnostic cannot be handled by medical services in resource-poor regions where HIV is endemic. Addressing this shortfall, commercialized point-of-care (POC) CD4 cell count systems are now available in such regions. A number of newer devices will also soon be on the market, some the result of recent maturing of charity-funded initiatives. Many of the current and imminent devices are enabled by microfluidic solutions, and this review will critically survey and analyze these POC technologies for CD4 counting, both on-market and near-to-market deployment. Additionally, promising technologies under development that may usher in a new generation of devices will be presented.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3lc50213aDOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
July 2013
15 Reads
7 PubMed Central Citations(source)

Publication Analysis

Top Keywords

devices will
8
cd4 counting
8
start patient
4
art reliable
4
patient art
4
devices enabled
4
decision making
4
making process
4
imminent devices
4
process start
4
current imminent
4
observe decline
4
decline number
4
number cd4
4
cd4
4
monitoring observe
4
enabled microfluidic
4
common method
4
method monitoring
4
reliable common
4

References

(Supplied by CrossRef)
Article in Science
Barré-Sinoussi et al.
Science 1983
Article in Science
Gallo et al.
Science 1983
Article in Science
Sarngadharan et al.
Science 1984
Article in Lancet
Jahn et al.
Lancet 2008
Article in AIDS
Reniers et al.
AIDS 2009
Article in Clin. Exp. Immunol.
Bofill et al.
Clin. Exp. Immunol. 1992
Article in Clin. Infect. Dis.
Castro et al.
Clin. Infect. Dis. 1993
Article in PLoS Med.
Rosen et al.
PLoS Med. 2011
Article in PLoS One
Losina et al.
PLoS One 2010
Article in Lancet
Jani et al.
Lancet 2011
Article in Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
Grundy et al.
Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention 2011

Similar Publications

Antimicrobial and antioxidant activities of triterpenoid and phenolic derivatives from two Cameroonian Melastomataceae plants: Dissotis senegambiensis and Amphiblemma monticola.

BMC Complement Altern Med 2018 May 16;18(1):159. Epub 2018 May 16.

Laboratory of Microbiology and Antimicrobial substances, Department of Biochemistry, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon.

Background: Antimicrobial resistance is a serious threat against humankind and the search for new therapeutics is needed. This study aims to investigate the antimicrobial and antioxidant activities of ethanol extracts and compounds isolated from Dissotis senegambiensis and Amphiblemma monticola, two Cameroonian Melastomataceae species traditionally used for the treatment of fever, malaria and infectious diseases.

Methods: The plant extracts were prepared by maceration in ethanol. Read More

View Article
May 2018
17 Reads
2.02 Impact Factor

The effect of various adhesives, enamel etching, and base treatment on the failure frequency of customized lingual brackets: a randomized clinical trial.

Eur J Orthod 2018 May;40(3):249-253

CHIR- Unit Dentistry - ORHE, department of Orthodontics, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan, Brussel, Belgium.

Objectives: The aim of this paper was to compare failure differences in precious metal customized lingual brackets bonded with three adhesive systems. Also, differences in failure of non-precious metal brackets with and without a silicatized base layer bonded with the same adhesive, as well as the influence of enamel etching prior to using a self-etching dual cure resin were explored.

Materials/methods: Five different groups were defined in a semi-randomized approach. Read More

View Article
May 2018
50 Reads
1.39 Impact Factor

An intermediate term benefits and complications of gamma knife surgery in management of glomus jugulare tumor.

World J Surg Oncol 2016 Feb 15;14(1):36. Epub 2016 Feb 15.

Department of Neurosurgery and Gamma Knife center, International Medical Center (IMC), Cairo, Egypt.

Glomus tumors are rare skull base slow-growing, hypervascular neoplasms that frequently involve critical neurovascular structures, and delay in diagnosis is frequent. Surgical removal is rarely radical and is usually associated with morbidity or mortality. Gamma knife surgery (GKS) has gained an increasing dependable role in the management of glomus jugulare tumors, with high rate of tumor growth control, preserving or improving clinical status and with limited complications. Read More

View Article
February 2016
31 Reads
2 PubMed Central Citations(source)
1.20 Impact Factor

Determination of band structure parameters and the quasi-particle gap of CdSe quantum dots by cyclic voltammetry.

Chemphyschem 2008 Dec;9(17):2574-9

Department of Chemistry and DST center for Nanoscience, University of Pune, Ganeshkhind, Pune 411007, India.

Band structure parameters such as the conduction band edge, the valence band edge and the quasi-particle gap of diffusing CdSe quantum dots (Q-dots) of various sizes were determined using cyclic voltammetry. These parameters are strongly dependent on the size of the Q-dots. The results obtained from voltammetric measurements are compared to spectroscopic and theoretical data. Read More

View Article
December 2008
17 Reads
2 PubMed Central Citations(source)
3.42 Impact Factor

Causes of the post-concussional syndrome.

Acta Neurol Scand Suppl 1974 ;56:3-144

View Article
September 1974
18 Reads
8 PubMed Central Citations(source)